Larvol Delta - Gates-Biomanufacturing-Facility-Announces-Manufacture-of-Recombinant-Protein--Alzheimer39s-Disease-Vaccine-for-Institute-for-Molecular-Medicine39s-Clinical-Trials

AV-1980R - Nuravax

https://www.prnewswire.com/news-releases/gates-biomanufacturing-facility-announces-manufacture-of-recombinant-protein---alzheimers-disease-vaccine-for-institute-for-molecular-medicines-clinical-trials-301668444.html

Nov 4, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next